Fabrice Ngoh Njotu

Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics

Jessica Pougoue Ketchemen, Hanan Babeker, Anjong Florence Tikum et al. · British Journal of Cancer · 2023 · 16 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer

Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 16 citations

Medicine, Medicinal Chemistry, Oncology +11

Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate

Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker et al. · Clinical Cancer Research · 2024 · 13 citations

Medicine, Oncology, Pharmacology +17

²²⁵ Ac/ ⁸⁹ Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer

Hanan Babeker, Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen et al. · Journal of Nuclear Medicine · 2025 · 11 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Effectiveness of²²⁵Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models

Anjong Florence Tikum, Jessica Pougoue Ketchemen, Alireza Doroudi et al. · Journal of Nuclear Medicine · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17